Akebia Therapeutics Inc
Change company Symbol lookup
Select an option...
AKBA Akebia Therapeutics Inc
JPM-K JPMorgan Chase & Co
KLAC KLA Corp
CNVY Convey Health Solutions Holdings Inc
EBAY eBay Inc
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on producing medicines for people living with kidney disease. Its lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), designed to mimic the physiologic effect of altitude on oxygen availability. In addition, it has a commercial product, Auryxia (ferric citrate), which is marketed for two indications in the United States: the control of serum phosphorus levels in adult patients with dialysis-dependent (DD)-CKD or the hyperphosphatemia indication, and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis dependent (NDD)-CKD or the IDA indication. Its ferric citrate is also approved and marketed in Japan as an oral treatment for the improvement of hyperphosphatemia in patients with CKD.

Closing Price
$0.4045
Day's Change
-0.0005 (-0.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.405
Day's Low
0.3801
Volume
(Average)
Volume:
5,517,160

10-day average volume:
5,083,636
5,517,160
  • Prev Close
    0.405
  • Today's Open
    0.405
  • Day's Range
    0.3801-0.405
  • Avg Vol (10-day)
    5.1M
  • Last (time)
    4:00p ET 08/09/22
  • Last (size)
    8.0K
  • 52-Wk Range
    0.30 - 3.35
    LowHigh
  • (11/03/21 - 06/16/22)
    34.83%
  • 134.6%
  • Market Cap
    74.4M
  • Shares Outstanding
    183.8M
  • -1.61
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 47.29
  • (% of float 07/15/22)
    6.42

Latest News

August 04, 2022
4:05 pm ET
PR Newswire
4:02 pm ET
PR Newswire
August 02, 2022
4:05 pm ET
PR Newswire
July 26, 2022
8:00 am ET
PR Newswire
July 05, 2022
4:05 pm ET
PR Newswire
July 01, 2022
10:50 am ET
PR Newswire
June 30, 2022
4:05 pm ET
PR Newswire
June 03, 2022
8:30 am ET
PR Newswire
June 02, 2022
5:05 pm ET
PR Newswire
May 19, 2022
8:30 am ET
PR Newswire
May 13, 2022
11:15 am ET
Accesswire
10:42 am ET
Newsfile
10:32 am ET
Globe Newswire
5:45 am ET
PR Newswire
May 12, 2022
5:45 am ET
PR Newswire
March 31, 2022
6:56 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.